EQS-Adhoc

    141 Aufrufe 141 0 Kommentare 0 Kommentare

    Symrise AG decides to divest its terpenes business and makes non-cash impairment. Symrise AG's investment in Swedencare AB is subject to a non-cash impairment.

    Für Sie zusammengefasst
    • Symrise AG to divest terpenes business, impairments noted.
    • Non-cash impairment of €145M affects Q4 2025 EBIT.
    • Swedencare AB investment impairment of €150M impacts EBITDA.
    EQS-Adhoc - Symrise AG decides to divest its terpenes business and makes non-cash impairment.  Symrise AG's investment in Swedencare AB is subject to a non-cash impairment.

    EQS-Ad-hoc: Symrise AG / Key word(s): Miscellaneous
    Symrise AG decides to divest its terpenes business and makes non-cash impairment. Symrise AG's investment in Swedencare AB is subject to a non-cash impairment.

    12-Jan-2026 / 19:27 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
    The issuer is solely responsible for the content of this announcement.


    Disclosure of inside information pursuant to Article 17 of Regulation (EU) No 596/2014

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Symrise AG!
    Long
    71,15€
    Basispreis
    0,57
    Ask
    × 13,63
    Hebel
    Zum Produkt
    Blatt
    Short
    81,25€
    Basispreis
    0,57
    Ask
    × 13,62
    Hebel
    Zum Produkt
    Blatt
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

     

    Symrise AG decides to divest its terpenes business and makes non-cash impairment

    Symrise AG's investment in Swedencare AB is subject to a non-cash impairment

     

    This publication contains two separate independent inside information.
     
    1. Symrise AG is in advanced talks with potential interested parties about the sale of its terpenes business. This is a structured bidding process. Based on the offers received so far, the international accounting standard IFRS 5 will be applied. In this context, a non-cash impairment charge of approximately EUR 145 million is recorded in the fourth quarter of 2025. This has a negative impact on Symrise AG's EBIT.
    2. According to preliminary calculations, a non-cash impairment in the value of the investment in Sweden-listed Swedencare AB will lead to a material deviation from the expected result for the 2025 financial year compared to current capital market expectations and the published forecast. Symrise AG will record a non-cash impairment charge of the investment in Swedencare AB in the amount of EUR 150 million in the fourth quarter of 2025. This has a negative impact on EBITDA. 
    Neither measure has any impact on the liquidity and/or operating business of Symrise AG. They will be adjusted as part of the earnings reporting.
     

    Media contact:                                               Investor Relations Contact
    Bernhard Kott                                                  René Weinberg
    Phone: +49 (0)5531 90-1721                           Phone: +49 (0)5531 90-1879
    E-mail: bernhard.kott@symrise.com               E-mail: rene.weinberg@symrise.com
     


    End of Inside Information

    12-Jan-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    View original content: EQS News


    Language: English
    Company: Symrise AG
    Mühlenfeldstraße 1
    37603 Holzminden
    Germany
    Phone: +49 (0)5531 90 0
    E-mail: ir@symrise.com
    Internet: www.symrise.com
    ISIN: DE000SYM9999, DE000SYM7787, DE000SYM7704
    WKN: SYM999
    Indices: DAX
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 2258790

     
    End of Announcement EQS News Service

    2258790  12-Jan-2026 CET/CEST

    Symrise

    +0,45 %
    +3,22 %
    +4,10 %
    +2,88 %
    -23,86 %
    -20,42 %
    -27,76 %
    +34,15 %
    +350,92 %
    ISIN:DE000SYM9999WKN:SYM999




    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc Symrise AG decides to divest its terpenes business and makes non-cash impairment. Symrise AG's investment in Swedencare AB is subject to a non-cash impairment. EQS-Ad-hoc: Symrise AG / Key word(s): Miscellaneous Symrise AG decides to divest its terpenes business and makes non-cash impairment. Symrise AG's investment in Swedencare AB is subject to a non-cash impairment. 12-Jan-2026 / 19:27 CET/CEST …

    Profitieren Sie von unserem Alleinstellungsmerkmal als den zentralen verlagsunabhängigen Wissens-Hub für einen aktuellen und fundierten Zugang in die Börsen- und Wirtschaftswelt, um strategische Entscheidungen zu treffen.
    • ✅ Größte Finanz-Community Deutschlands
    • ✅ über 550.000 registrierte Nutzer
    • ✅ rund 2.000 Beiträge pro Tag
    • ✅ verlagsunabhängige Partner ARIVA, FinanzNachrichten und BörsenNews
    • ✅ Jederzeit einfach handeln beim SMARTBROKER+
    • ✅ mehr als 25 Jahre Marktpräsenz
    Aktien von A - Z: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    wallstreetONLINE bei X wallstreetONLINE bei Instagram wallstreetONLINE bei Facebook wallstreetONLINE bei Youtube wallstreetONLINE bei LinkedIn
    Unsere Apps: Apple App Store Icon Google Play Store Icon
    Wenn Sie Kursdaten, Widgets oder andere Finanzinformationen benötigen, hilft Ihnen ARIVA gerne. 

    Unsere User schätzen wallstreet-online.de: 4.8 von 5 Sternen ermittelt aus 285 Bewertungen bei www.kagels-trading.de
    Zeitverzögerung der Kursdaten: Deutsche Börsen +15 Min. NASDAQ +15 Min. NYSE +20 Min. AMEX +20 Min. Dow Jones +15 Min. Alle Angaben ohne Gewähr.
    Copyright © 1998-2026 Smartbroker Holding AG - Alle Rechte vorbehalten.
    Mit Unterstützung von: Ariva Smartbroker+
    Daten & Kurse von: TTMzero